Answers are grounded in this paper and cite their sources.
This study suggest that the in vitro cytotoxic effect through proteasome inhibition by bortezomib can be increased substantially with low doses of the purine nucleoside analogues, 2-CdA and FA, and that this effect on B-CLL cell is selectively higher than on normal, CD3-positive lymphocytes.
No takes yet. Share an insight, caveat, or question.
Duechler et al. (2005) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: